Bifogade filer
Kurs
+4,16%
Likviditet
0,48 MSEK
Kalender
Est. tid* | ||
2025-08-19 | 08:30 | Kvartalsrapport 2025-Q2 |
2025-05-13 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2025-05-12 | - | Årsstämma |
2025-05-08 | - | Kvartalsrapport 2025-Q1 |
2025-02-21 | - | Bokslutskommuniké 2024 |
2024-12-19 | - | Extra Bolagsstämma 2024 |
2024-11-29 | - | Kvartalsrapport 2024-Q3 |
2024-08-23 | - | Kvartalsrapport 2024-Q2 |
2024-06-05 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2024-06-04 | - | Årsstämma |
2024-04-26 | - | Kvartalsrapport 2024-Q1 |
2024-02-16 | - | Bokslutskommuniké 2023 |
2023-11-30 | - | Kvartalsrapport 2023-Q3 |
2023-10-02 | - | Extra Bolagsstämma 2023 |
2023-08-31 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2023-05-04 | - | Årsstämma |
2023-04-28 | - | Kvartalsrapport 2023-Q1 |
2023-02-24 | - | Bokslutskommuniké 2022 |
2022-11-11 | - | Kvartalsrapport 2022-Q3 |
2022-08-12 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2022-05-04 | - | Årsstämma |
2022-04-28 | - | Kvartalsrapport 2022-Q1 |
2022-02-24 | - | Bokslutskommuniké 2021 |
2021-11-12 | - | Kvartalsrapport 2021-Q3 |
2021-08-11 | - | Kvartalsrapport 2021-Q2 |
2021-04-29 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2021-04-28 | - | Årsstämma |
2021-04-28 | - | Kvartalsrapport 2021-Q1 |
2021-02-18 | - | Bokslutskommuniké 2020 |
2020-11-13 | - | Kvartalsrapport 2020-Q3 |
2020-08-28 | - | Kvartalsrapport 2020-Q2 |
2020-05-13 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2020-05-12 | - | Årsstämma |
2020-05-12 | - | Kvartalsrapport 2020-Q1 |
2020-02-25 | - | Bokslutskommuniké 2019 |
2019-11-19 | - | Kvartalsrapport 2019-Q3 |
2019-08-16 | - | Kvartalsrapport 2019-Q2 |
2019-05-17 | - | Kvartalsrapport 2019-Q1 |
2019-04-26 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2019-04-25 | - | Årsstämma |
2019-02-13 | - | Bokslutskommuniké 2018 |
2018-11-22 | - | Kvartalsrapport 2018-Q3 |
2018-08-31 | - | Kvartalsrapport 2018-Q2 |
2018-04-25 | - | Kvartalsrapport 2018-Q1 |
2018-03-22 | - | X-dag ordinarie utdelning ACUC 0.00 SEK |
2018-03-21 | - | Årsstämma |
2018-02-06 | - | Bokslutskommuniké 2017 |
2017-11-09 | - | Kvartalsrapport 2017-Q3 |
2017-08-30 | - | Kvartalsrapport 2017-Q2 |
2017-05-15 | - | Kvartalsrapport 2017-Q1 |
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
AcuCort AB (Spotlight Stock Market: ACUC) received the Second Round Assessment Report from the Swedish MPA as planned in July. Thanks to the ambitious work answering the authority's questions in the previous round, the Second Round Assessment Report is less extensive and no major issues can be foreseen
AcuCort received the Second Round Assessment Report from the Swedish Medical Products Agency (MPA), for the ISICORT® national approval process, as per the application timeline. Now having made an assessment of the remaining questions, with regulatory support and further evaluation by the AcuCort Board of Directors, the company can conclude that a large proportion of topics have been nicely completed and the outstanding topics should be manageable. The Second Round Reply will be submitted by AcuCort on August 11[th], 2020.
"As previously communicated, we worked together with our manufacturing and regulatory partners to give good and complete answers to the First Round Assessment. Now we see that a lot of the topics are nicely completed. A smaller proportion of topics needs some further clarification, and we have some updates to the phrasing of product information to complete now in the second round. Altogether, his makes us confident about the planning ahead," says Ann Gidner, CEO of AcuCort AB.
For more information, please contact:
Ann Gidner, interim CEO, AcuCort AB
Phone: +46 (0)72 315 1414
Email: ann.gidner@acucort.se